Skip to main content

Table 1 Patterns of serum IIRPCs in patients with benign breast diseases and breast cancer

From: Development and validation of a model and nomogram for breast cancer diagnosis based on quantitative analysis of serum disease-specific haptoglobin N-glycosylation

 

a

b

c

d

e

f

g

Benign breast disease n

142

86

16

4

0

3

1

Breast cancer n

143

103

10

9

2

4

0

Total N

285

189

26

13

2

7

1

Percentage %

54.5

36.1

5.0

2.5

0.4

1.3

0.2